Estimates Revisions Basilea Pharmaceutica AG
Stocks
BSLN
CH0011432447
Biotechnology & Medical Research
|
Market Closed -
Swiss Exchange
16:31:52 21/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 64.60 CHF | -1.52% |
|
+21.89% | +18.10% |
| 08-18 | Basilea Pharmaceutica Ag Raises Earnings Guidance for the Full Year 2026 | CI |
| 08-18 | Swiss Market Index Closes Higher; Huber+Suhner Shares Drop | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| - | |||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- BSLN Stock
- Consensus Basilea Pharmaceutica AG
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
